Dramatic improvement of primary cutaneous amyloidosis with thalidomide

Eur J Dermatol. 2011 Mar-Apr;21(2):270-1. doi: 10.1684/ejd.2010.1228.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amyloidosis / drug therapy*
  • Amyloidosis / pathology
  • Humans
  • Immunomodulation / drug effects
  • Immunosuppressive Agents / pharmacology
  • Immunosuppressive Agents / therapeutic use*
  • Skin Diseases / drug therapy*
  • Skin Diseases / pathology
  • Thalidomide / pharmacology
  • Thalidomide / therapeutic use*

Substances

  • Immunosuppressive Agents
  • Thalidomide